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 Abstract
Objectives: Sex hormones are specific factors contributing to the regulation of cardiovascular system. Studies on 
the effects of hormonal fluctuations during the menstrual cycle on hemodynamics and arterial stiffness in young 
women are limited and provide conflicting results.
Aim: The aim of the study was to assess arterial stiffness, peripheral/central blood (pBP and cBP) and pulse (pPP 
and cPP) pressures throughout the single, natural menstrual cycle (early follicular [EFP], late follicular [LFP] and 
midluteal [LP] phase).
Materials and methods: Forty two healthy, regularly menstruating women (28.6±5.1 yrs of age; BMI 22.0±3.5 
kg/m2) were evaluated during EFP (Estradiol [E], FSH, LH, PRL, TSH, Testosterone [T], DHEAS, and SHBG), LFP 
(E, FSH, LH) and LP (Progesterone, E, FSH, LH). Transvaginal ultrasound was performed to confirm ovulatory 
cycle. Resting radial and aortic BP were assessed noninvasively and continuously using tonometric measurement 
of peripheral PP wave-PPW (Colin BMP7000, Japan) and on-line reconstruction of central PPW (Sphygmocor Mx, 
Australia) at EFP, LFP and LP. ANOVA and Friedman test were used in statistical analysis.
Results: There were no significant differences in systolic/diastolic BP and PP both at the periphery and at ascend-
ing aorta throughout the menstrual cycle. Comparable observations of no interphasal differences were noted for 
peripheral Augmentation Index (AI). Central AI and augmentation pressure (AP) were significantly lower in LP than 
in LFP (by 4%; p<0.05 and by 37%; p<0.05, respectively).
Conclusions: We demonstrated significant differences in mechanical properties of large arteries at the midluteal 
phase of natural menstrual cycle. We conclude that sex hormones may play role in the regulation of arterial stiffness 
in the reproductive age women.
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Introduction
Menstrual	cycle	has	been	thoroughly	described	in	terms	of	
complex	hormonal	fluctuations:		rises	in	the	periovulatory	estra-
diol	and	luteal	progesterone	concentrations,	paralleled	by		ovari-
an	and	endometrial	changes.	Estradiol	and	progesterone	receptors	
were	localized	in	the	vascular	smooth	muscles	and	endothelium.	
Both	in	the	experimental	and	clinical	studies	exogenous	estradiol	
was	shown	to	have	vasodilatory	effects	acting	indirectly,	through	
nitric	 oxide	 and	 prostacyclin,	 or	 directly	 -	modulating	 calcium	
channel	activity	in	myocytes	[1].	
However	 large,	 randomized	 clinical	 studies	 in	 postmeno-
pausal	women	treated	with	hormone	replacement	 therapy	dem-
onstrated	 adverse	 effects	 of	 progestogens	 on	 vascular	 system.	
Medroxyprogesterone	acetate	antagonized	vasodilatory	effect	of	
estrogens	by	inhibiting	nitric	oxide	production	and	promoting	va-
soconstriction	[2].
Non-invasive	pulse	wave	 analysis	 allows	 to	 assess	 arterial	
wave	reflection	and	to	quantify	central	arterial	pressure	and	stiff-
ness.	Measurements	 of	 central	 pressures,	when	 compared	with	
peripheral	ones,	provide	better	markers	for	arterial	elasticity	and	
possible	vascular	damage.	On	the	other	hand,	arterial	stiffness	is	
a	well-validated	noninvasive	measure	of	cardiovascular	risk	and	
a	good	predictor	for	cardiovascular	events	[3,	4].	
The	 effects	 of	 endogenous	 steroids	 on	 the	 cardiovascular	
system	and	its	hemodynamic	properties	during	the	natural	men-
strual	cycle	in	healthy	women	of	reproductive	age	have	not	been	
investigated	comprehensively.	Only	few	studies	have	examined	
the	associations	between	cyclic	variations	in	sex	hormones,	pulse	
wave	reflection	and	arterial	stiffness.	
Additionally,	 presented	 data	 are	 conflicting	 and	 the	 study	
groups	relatively	small	[5-8].
Objectives
Therefore	 the	 aim	 of	 the	 current	 study	 was	 to	 evaluate	
peripheral	 and	 central	 hemodynamic	 characteristics	 and	 the	
mechanical	properties	of	arterial	vessels	 throughout	 the	natural	
menstrual	cycle	at	follicular,	periovulatory	and	midluteal	phases	
in	healthy	women	of	reproductive	age.
Material and methods
Subjects:
Forty-two	healthy	regularly	menstruating	(29	±	2	days)	nor-
motensive	women	 (mean	 age	 28.6	 ±	 5.1	 years)	were	 recruited	
to	 the	 study	 through	 announcements	 and	 educational	 action	 at	
the	universities	and	colleges	in	Poznan	in	the	period	from	2011	
till	2013.	No	female	volunteers	were	recruited	form	the	students	
and	employees	of	Poznan	University	of	Medical	Sciences.	None	
of	 the	 subjects	 had	hyperandrogenemia,	 hyperandrogenism	nor	
hyperprolactinemia	diagnosed.	No	clinical	signs	and	symptoms	
of	any	endocrinopathy	were	identified	in	all	participants.	Women	
with	 history	 of	 hypertension,	 diabetes	mellitus,	 cardiovascular,	
renal,	 and	 neoplastic	 disease	 were	 not	 recruited	 to	 the	 study.	
Bioethics	Committee	at	Poznan	University	of	Medical	Sciences	
approved	the	study	protocol	and	a	written	informed	consent	was	
obtained	from	all	participants.	All	subjects	were	not	taking	any	
form	of	hormonal	contraception,	other	steroids	nor	any	form	of	
treatment	to	affect	blood	pressure	and	hormonal	status	for	the	pre-
ceding	two	months.	None	of	the	women	declared	to	smoke.
 Streszczenie    
Hormony płciowe są ważnymi czynnikami biorącymi udział w regulacji funkcji układu krążenia. Dotychczasowe ba-
dania oceniające wpływ zmian stężeń hormonów płciowych w przebiegu fizjologicznego cyklu miesiączkowego na 
sztywność naczyń tętniczych oraz parametry hemodynamiczne są nieliczne i przedstawiają sprzeczne wniosków.
Cel pracy: Celem pracy była ocena parametrów opisujących sztywność naczyniową oraz obwodowe i centralne 
ciśnienie tętnicze (pBP, cBP) i ciśnienie tętna (cPP, pPP) w przebiegu naturalnego cyklu miesiączkowego (we wcze-
snej fazie folikularnej [EFP], w późnej fazie folikularnej [LFP] i w fazie lutealnej [LP]). 
Materiał i metody: Przebadano 42 regularnie miesiączkujące kobiety (średnia wieku 28,6±5,1 lat, BMI 22,0±3,5 
kg/m2) we EFP (Estradiol [E], FSH, LH, PRL, TSH, Testosteron [T], DHEAS, SHBG), w LFP (E, FSH, LH) oraz LP 
(Progesteron, E, FSH, LH). W celu potwierdzenia cyklu owulacyjnego wykonano przezpochwowe badanie ultraso-
nograficzne. Ocenę pBP (tętnica promieniowa) i cBP (aorta wstępująca) wykonano w sposób nieinwazyjny metodą 
tonometrycznych pomiarów obwodowej fali tętna [PPW] (Colin BMP 7000, Japonia) z następową rekonstrukcją 
w czasie rzeczywistym centralnej PPW (Sphygmocor Mx, Australia) w fazie: EFP, LFP i LP. Analizę statystyczną 
wykonano przy pomocy testu ANOVA i testu Friedmana.
Wyniki: Nie zaobserwowano istotnych statystycznie różnic w wartościach skurczowego i rozkurczowego BP oraz 
PP na obwodzie i na poziomie tętnicy wstępującej w przebiegu cyklu miesiączkowego. Podobne wyniki świadczą-
ce o braku różnic między fazami cyklu uzyskano dla obwodowego wskaźnika wzmocnienia [AI]. Centralny AI oraz 
ciśnienie wzmocnienia [AP] były statystycznie istotnie niższe w LP w porównaniu z LFP (odpowiednio o 4%, p<0,05 
oraz o 37%, p<0,05).
Wnioski: W  przedstawionej pracy zaobserwowaliśmy występowanie istotnych różnic we właściwościach 
mechanicznych dużych naczyń tętniczych w  środkowej fazie lutealnej fizjologicznego cyklu miesiączkowego. 
Przedstawione wyniki wskazują, iż hormony płciowe mogą brać udział w regulacji sztywności naczyń tętniczych 
u kobiet w wieku rozrodczym.
 Słowa kluczowe: cykl miesiączkowy / estrogen / fazy cyklu miesiączkowego /  
     / odbicie fali / sztywność naczyniowa / tonometria aplanacyjna /
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Study protocol:
The	study	was	conducted	during	the	single,	natural	menstru-
al	cycle	at	three	time	points	corresponding	to:
•	 Early	follicular	phase	(EFP,	between	3rd	and	5th	day	of	the	
menstrual	cycle).
•	 Late	follicular	phase	(LFP,	between	11th	and	14th day of 
the	menstrual	cycle).
•	 Midluteal	 phase	 (LP,	 between	 19th	 and	 22nd	 day	 of	 the	
menstrual	cycle).
At	 the	 initial	 visit	 careful	 medical	 history	 was	 taken	 and	
the	physical	as	well	as	gynecologic	exam	performed.	Hormonal	
evaluations	 were	 performed	 at	 each	 visit	 and	 venous	 blood	
was	 collected	 between	 7	 and	 9	 a.m	 after	 an	 overnight	 fasting.	
Gynecological	 transvaginal	 ultrasound	 scan	 (Aloka	 ProSound	
α7;	Aloka	 Co,	 Ltd,	 Tokio,	 Japan)	 was	 performed	 at	 the	 three	
described	time	points	in	order	to	assess	the	size	and	number	of	
growing	ovarian	follicles,	confirm	the	presence	of	corpus	luteum	
and	to	assess	changes	 in	 the	endometrial	 texture	and	thickness.	
Evaluation	of	 the	 cardiovascular	 system	was	performed	on	 the	
same	day,	in	the	morning,	at	each	of	described	time	points	of	the	
menstrual	cycle.
Hormonal assays:
Estradiol	(E2),	LH,	FSH	and	progesterone	(PROG;	measured	
only	in	the	mid-luteal	phase)	were	determined	by	specific	elec-
trochemiluminescence	assays	 (automated	Cobas	e601	 immuno-
analyzer,	Roche	Polska	sp	z	o.o.,	Warsaw,	Poland).	Testosterone,	
TSH,	prolactin,	DHEAS,	and	SHBG	were	assessed	only	at	 the	
early	follicular	phase	with	specific	electrochemiluminescence	as-
says	as	described	above.
Evaluation of the cardiovascular system:
Blood	 pressure	 and	 pulse	 wave	 measurements	 were	
performed	in	the	morning	hours	in	the	supine	position,	after	15	
minute	 rest.	 Radial	 and	 aortal	 blood	 pressures	 were	 assessed	
noninvasively	 and	 continuously	 using	 tonometric	measurement	
of	peripheral	pulse	pressure	wave	(PPW)	with	piezoelectric	wrist	
tonometer	(Colin	BMP7000,	Japan).	The	brachial	blood	pressure	
recorded	 with	 oscillometric	 method	 (M-5,	 Omron	 Healthcare,	
Kyoto,	 Japan)	 was	 used	 for	 the	 calibration.	 On-line	 real-time	
reconstruction	 of	 central	 PPW	 was	 performed	 (Sphygmocor	
Mx,	Australia)	with	 the	use	of	validated	 transfer	 function	after	
acquisition	of	ten	sequential	pulse	wave	forms	[4,	9,	10].
The	measurements	were	performed	at	each	phase	of	the	men-
strual	cycle	and	the	following	derived	hemodynamic	parameters	
were	analyzed:
•	 Peripheral	 (radial)	 blood	 pressure	 (peripheral	 Systolic	
Pressure	–	pSP,	peripheral	Diastolic	Pressure	–	pDP).
•	 Central	(aortic)	blood	pressure	(central	Systolic	Pressure	
–	cSP,	central	Diastolic	Pressure	–	cDP).
•	 Peripheral	pulse	pressure	(pPP)	defined	as	the	difference	
between	pSP	and	pDP.
•	 Central	pulse	pressure	(cPP)	defined	as	the	difference	be-
tween	cSP	and	cDP.
•	 Augmentation	Pressure	(AP),	a	descriptor	of	arterial	stiff-
ness	derived	from	central	pulse	wave	analysis,	describes	
the	portion	of	the	cSP	contributed	by	the	early	reflected	
wave.
•	 Augmentation	 index	 (AI)	 defined	 as	 the	 difference	 be-
tween	the	first	(early)	and	the	second	(late)	systolic	peaks	
on	 the	 arterial	 waveform	 expressed	 as	 a	 percentage	 of	
pulse	pressure	(peripheral	–	pAI,	 recorded	on	 the	radial	
pressure	waveform,	 and	 central	 –	 cAI,	 recorded	 on	 the	
reconstructed	aortic	pressure	waveform).	AI	is	considered	
as	the	indirect	descriptor	of	wave	reflection,	arterial	stiff-
ness	 as	well	 as	 the	 predictor	 of	 adverse	 cardiovascular	
events	[11].
AI	and	AP	are	related	to	the	reflected	pressure	waves	from	
the	 peripheral	 arterial	 system,	 either	 as	 in	 a	 direct	 increase	 in	
pressure	at	the	heart	from	the	reflected	wave	(AP)	or	as	a	percent-
age	of	pulse	pressure	(AI).
Statistical analysis:
Statistical	analysis	was	performed	after	checking	the	normal-
ity	of	data	distribution	(Shapiro-Wilk	test),	with	the	ANOVA	test	
(normal	 distribution)	 or	 Friedman	 test	 (no	 normal	 distribution)	
with	the	appropriate	post-hoc	tests.	p<0.05	was	considered	as	sta-
tistically	significant.	The	results	are	presented	as	mean	±	standard	
deviation	(SD).
Results
Group characteristics
Table	I	lists	the	clinical	and	hormonal	characteristics	of	the	
study	subjects.
Biphasic	nature	of	the	menstrual	cycle	in	all	study	subjects,	
with	well	depicted	luteal	phase	was	confirmed	with	hormonal	and	
ultrasound	evaluations	(Table	II).
Heart	Rate	(HR)	is	a	parameter	that	may	significantly	affect	
other	hemodynamic	phenomena	and	 thus	variability	of	 the	HR	
during	the	menstrual	cycle	should	be	excluded	in	order	to	conduct	
further	 statistical	 analysis.	We	 found	no	 statistically	 significant	
differences	in	HR	values	between	researched	phases	of	the	men-
strual	cycle	(EFP	vs.	LFP	vs.	LP	;	HR	=	71.6	±	9.3/min	vs.	71.0	±	
8.9/min	vs.	72.2	±	9.3/min,	respectively;	p=ns).
Peripheral blood pressure
There	were	no	significant	differences	 in	 the	peripheral	 (ra-
dial	 artery)	 blood	 pressure	 (systolic,	 diastolic,	 pulse)	 between	
the	 three	 phases	 of	 the	menstrual	 cycle	 (EFP	 vs.	 LFP	 vs.	 LP;	
Table I. Clinical and hormonal characteristics of the study subjects.
Characteristic Mean +/- SD
Age [yrs] 28.6 ± 5.1
Weight [kg] 62.2 ± 10.9
Height [cm] 168 ± 6
BMI [kg/m2] 22.0 ± 3.5
Testosterone [ng/ml] 0.33 ± 0.14
SHBG [nmol/l] 70.0 ± 31.6
DHEAS [μmol/l] 6.5 ± 2.5
PRL [ng/ml] 14.1 ± 6.8
TSH [μIU/ml] 1.83 ± 0.89
BMI – body mass index
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pSP	105.4	±	9.7	mmHg	vs.	105.9	±	9.4	mmHg	vs.	104.4	±	11.1	
mmHg,	respectively,	p=ns	;	pDP	63.9	±	7.3	mmHg	vs.	64.3	±	8.3	
mmHg	vs.	63.7	±	7.8	mmHg,	respectively,	p=ns	;	pPP	41.6	±	6.4	
mmHg	vs.	41.6	±	7.7	mmHg	vs.	40.7	±	6.1	mmHg,	respectively,	
p=ns;	presented	in	Figure	1).
Central blood pressure
Similarly,	no	interphasal	differences	were	obtained	for	cen-
tral	blood	pressure	parameters	corresponding	 to	 the	pressure	 in	
the	 ascending	 aorta.	 Central	 systolic,	 diastolic	 and	 pulse	 pres-
sure	 showed	 no	 statistically	 significant	 differences	 at	 the	 three	
time	points	 investigated	 (EFP	vs.	LFP	vs.	LP	 ;	 cSP	90.9	±	9.1	
mmHg	vs.	92.0	±	9.4	mmHg	vs.	89.7	±	10.0	mmHg	respectively,	
p=ns;	cDP	64.9	±	7.5	mmHg	vs.	65.4	±	8.3	mmHg	vs.	64.7	±	7.9	
mmHg	respectively,	p=ns	and,	cPP	26.1	±	4.6	mmHg	vs.	26.7	±	
5.3	mmHg	vs.	25.0	±	3.7	mmHg	respectively,	p=ns	;	presented	
in	Figure	2).	
Parameters describing pulse pressure waveform and arterial 
stiffness
Peripheral	augmentation	index	(pAI)	showed	no	significant	
differences	 between	 the	 three	 selected	 phases	 of	 the	menstrual	
cycle	(LFP	vs.	EFP	vs.	LP;	pAI	=	55.6	±	11.8%	vs.	57.4	±	12.2%	
vs.	54.2	±	10.7%	respectively,	p=ns;	presented	in		Figure	3).	The	
pulse	pressure	wave	analysis	demonstrated	statistically	significant	
differences	in	the	values	of	parameters	describing	central	vascu-
lar	stiffness	at	the	investigated	menstrual	phases.	Central	AI	had	
significantly	lower	values	in	the	midluteal	phase	of	the	menstrual	
cycle	compared	to	the	late	follicular	phase	(by	4%;	cAI	LFP	vs.	
LP	=	113.4	±	12.5%	vs.	109.0	±	10.4%;	p<0.05).	There	were	no	
statistically	significant	differences	in	cAI	between	the	early	and	
late	follicular	as	well	as	the	early	follicular	and	midluteal	phases	
(cAI	EFP	vs.	LFP	=	111.3	±	12.0	%	vs.	113.4	±	12.5%,	p=ns;	cAI	
EFP	vs.	LP	=	111.3	±	12.0	%	vs.	109.0	±	10.4	%,	p=ns;	Figure	4).
Augmentation	pressure	(AP)	was	significantly	lower	in	the	
midluteal	phase	when	compared	to	the	late	follicular	phase	of	the	
menstrual	cycle	(by	37%	;	AP	LFP	vs.	LP	=	3.1	±	3.0	vs	1.9	±	2.3,	
p<0.05).	There	were	no	differences	in	AP	between	the	early	and	
late	follicular	as	well	as	the	early	follicular	and	midluteal	phases	
of	the	menstrual	cycle	(cAP	EFP	vs.	LFP	=	2.6	±	2.7	mmHg	vs.	
3.1	±	3.0	mmHg,	p=ns;	cAP	EFP	vs.	LP	=	2.6	±	2.7	mmHg	vs.	1.9	
±	2.3	mmHg,	p=ns;	Figure	5).
Discussion
In	the	present	study	we	have	observed	no	differences	in	the	
peripheral	 and	 central	 blood	 pressures	 (both	 systolic,	 diastolic,	
and	pulse)	measured	at	three	phases	of	the	natural	menstrual	cy-
cle:	 early	 follicular,	 late	 follicular,	 and	midluteal	 in	 young	 and	
healthy	 females.	 Interestingly	 the	pulse	pressure	wave	 analysis	
demonstrated	that	at	the	level	of	ascending	aorta	the	lowest	vas-
cular	 stiffness	 (described	 by	 central	 augmentation	 index	 [AI]	
and	augmentation	pressure	[AP])	was	recorded	in	the	midluteal	
phase.	There	was	no	interphasal	difference	in	the	vascular	stiff-
ness	measured	at	the	radial	artery	(peripheral	AI).
Early	 studies	 on	 the	 menstrual	 fluctuations	 of	 peripheral	
blood	pressures	showed	that	there	is	a	significant	rise	in	the	sys-
tolic	blood	pressure	in	the	early	[12]	and	late	follicular	(periovu-
latory)	phase	 [13],	presumably	due	 to	 increasing	estradiol	con-
centrations.	 Other	 investigators	 reported	 the	 decrease	 in	 radial	
diastolic	blood	pressure	in	midluteal	phase	of	the	cycle.	[14]	In	
a	more	 recent	 study	Adkisson	 et	 al.,	 showed	on	 a	 group	of	 23	
women	that	the	lowest	peripheral	blood	pressures,	both	systolic	
and	 diastolic,	were	 recorded	 in	 the	 late	 follicular	 phase	 of	 the	
cycle.	That	reduction	in	blood	pressures	correlated	inversely	with	
the	periovulatory	increase	in	serum	concentrations	of	a	potent	va-
sodilator	-	nitric	oxide.	[5]	However	these	observations	were	not	
confirmed	by	others.	[6,	7,	15]	
Our	results,	to	our	knowledge	derived	from	the	largest	female	
population	studied	up	to	date,	also	demonstrate	no	changes	in	pe-
ripheral	blood	pressures.	Well-described	physiological	hormonal	
fluctuations	-	estradiol	rise	in	the	late	follicular	phase	and	proges-
terone	increase	in	the	luteal	phase	seemed	to	have	no	significant	
effect	on	radial	arteries.	Short-term,	cyclic	hormonal	fluctuations	
in	the	natural	cycle	may	have	no	significant	effects	on	pressures.	
However	we	must	 take	into	consideration	that	peripheral	blood	
pressure	 shows	 relatively	 large	variability	 and	 is	 influenced	by	
complex	internal	regulatory	mechanisms	and	many	various	exter-
nal	factors.	Thus	significant	changes,	possibly	very	small,	might	
be	only	shown	on	much	larger	female	populations	investigated.
Peripheral	systolic	blood	pressure	(usually	measured	at	 the	
brachial	artery	or	as	in	our	study	at	 the	radial	artery)	is	not	 the	
direct	and	perfect	surrogate	for	the	central	pressure	(aorta	or	the	
central	 arteries),	 because	of	peripheral	 amplification.	There	 are	
multiple	studies	demonstrating	that	central	blood	pressure	better	
correlates	with	endothelial	dysfunction,	subendocardial	ischemia,	
atherogenesis	and	is	a	stronger,	more	sensitive	predictor	for	car-
diovascular	morbidity	 and	mortality	 than	 traditional	 peripheral	
blood	pressure.	[16,	17]	This	was	proven	both	in	the	diseased	as	
well	as	in	healthy	populations.	[18]
Table II. Hormonal and sonographic characteristics of the study subjects at the investigated phases of the menstrual cycle (EFP – early follicular phase, LFP – late follicular 
phase, LP – midluteal phase).
Phase of the menstrual cycle
Characteristic EFP LFP LP
Estradiol [pg/ml] 44.2 ± 15.5 218.8 ± 140.0 177.3 ± 90.35
FSH [mIU/ml] 6.9 ± 4.9 5.5 ± 3.7 3.6 ± 1.1
LH [mIU/ml] 5.9 ± 2.5 14.4 ± 15.5 5.7 ± 2.9
Progesterone [ng/ml] not measured not measured 13.2 ± 6.1
Endometrial thickness [mm] 4.0 ± 2.2 8.7 ± 2.2 11.3 ± 1.9
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Development	 of	 noninvasive	 and	 affordable	 technologies	
causes	 that	measurements	 of	 central	 vascular	 pressures	 are	 in-
creasingly	used,	however	the	number	of	studies	assessing	central	
pressures	during	the	natural	menstrual	cycle	in	young	and	healthy	
females	 is	 limited.	 In	 the	already	mentioned	study	Adkisson	et	
al.,	parallel	to	the	decrease	in	radial	pressures	in	the	periovulatory	
period,	 observed	 the	 lowest	 values	 of	 aortic,	 both	 systolic	 and	
diastolic,	pressures	at	 the	 late	 follicular	phase	of	 the	menstrual	
cycle.	During	 the	early	 luteal	phase	central	blood	pressures	 re-
mained	in	the	lower	ranges,	significantly	below	the	values	record-
ed	at	the	beginning	of	the	cycle	[5].	Nevertheless	these	findings	
were	not	confirmed	by	other	groups,	with	no	differences	observed	
throughout	 the	menstrual	 cycle	 [7,	 15].	 Similarly,	 in	 our	 study	
central	blood	pressures	 (systolic,	diastolic,	and	pulse	pressure),	
measured	 at	 the	 level	 of	 ascending	 aorta	 did	 not	 differ	 signifi-
cantly	between	the	phases	of	menstrual	cycle.	Normal	transitory	
surges	of	estradiol	and	progesterone	had	no	significant	effects	on	
 
Figure 1. Peripheral blood pressure (systolic – pSBP, diastolic – pDBP, and pulse – 
pPP) at the early follicular (EFP), late follicular (LFP), and midluteal phase (LP) of the 
menstrual cycle. Results shown as mean +/- SD.
 
Figure 4. Central Augmentation Index (cAI) at the early follicular (EFP), late 
follicular (LFP), and midluteal phase (LP) of the menstrual cycle. Results shown as 
mean +/- SD.
 
Figure 2. Central blood pressure (systolic – cSBP, diastolic – cDBP, and pulse – 
cPP) at the early follicular (EFP), late follicular (LFP), and midluteal phase (LP) of the 
menstrual cycle. Results shown as mean +/- SD.
 
Figure 5. Augmentation Pressure (cAP) at the early follicular (EFP), late follicular 
(LFP), and midluteal phase (LP) of the menstrual cycle. Results shown as mean 
+/- SD
 
Figure 3. Peripheral Augmentation Index (pAI) at the early follicular (EFP), late 
follicular (LFP), and midluteal phase (LP) of the menstrual cycle. Results shown as 
mean +/- SD.
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aortic	pressures.	To	date	only	one	study	demonstrated	changes	in	
the	central	pressures	in	premenopausal	females.	[5]	However	the	
study	was	performed	on	only	23	women,	of	much	younger	age	
than	our	population	(mean	age	below	20)	with	no	hormonal	(only	
estradiol	measured)	and	sonographic	confirmations	of	ovulation.	
On	contrary	our	studied	subjects	had	biphasic,	ovulatory	cycles	
that	were	thoroughly	documented	with	hormonal	evaluations	and	
sonographic	examinations	identifying	dominant	follicle	and	cor-
pus	luteum.
Analysis	of	the	central	pressure	waveform	allows	to	derive	
the	parameters	describing	arterial	 stiffness:	AP	and	AI.	Arterial	
stiffness	 influences	 the	velocity	of	 the	 reflected	wave	 from	 the	
peripheral	 vascular	 system	 and	 hence	 affects	 central	 pressures.	
Augmentation	 pressure	 is	 the	 additional	 pressure	 added	 to	 the	
forward	wave	by	the	reflected	wave	and	AI	is	the	ratio	between	
AP	and	pulse	pressure	 (central	 or	peripheral).	Both	descriptors	
of	arterial	stiffness	are	good,	independent	predictors	for	adverse	
cardiovascular	events	[19].
We	have	observed	no	fluctuations	in	peripheral	AI	through-
out	the	menstrual	cycle,	however	we	have	demonstrated	that	cen-
tral	vascular	stiffness	decreased	during	the	luteal	phase.	Previous	
studies	on	arterial	 stiffness	during	 the	menstrual	cycle	are	 lim-
ited	and	present	contradictory	results.	Papaioannou	et	al.	 found	
no	significant	changes	 in	arterial	 stiffness	during	 the	menstrual	
cycle	using	applanation	tonometry	on	a	group	of	32	women	[7].	
Comparable	findings	of	no	differences	in	central	AI	(though	on	
carotid	 artery)	between	different	phases	of	 the	menstrual	 cycle	
were	presented	by	others	[15].	Opposing	results	of	the	decrease	
in	arterial	stiffness	toward	the	end	of	the	follicular	phase	prior	to	
ovulation	were	presented	by	Adkisson	et	al	[5].	This	group	sug-
gested	that	at	least	in	part	the	mechanism	responsible	is	related	
to	 estrogen–mediated	 increase	 in	 nitric	 oxide	 production	 and	
bioavailability.	However	this	study	showed	no	comparable	tem-
poral	changes	in	central	or	peripheral	stiffness	when	measuring	
pulse	wave	velocity	[5].	Similar	results	of	an	increase	in	vascular	
elasticity	in	the	periovulatory	phase	were	also	presented	by	other	
groups,	that	used	different	methodologies.	Using	simultaneously	
ultrasound	and	applanation	tonometry,	Hayashi	et	al	showed	cy-
clical	changes	in	carotid	arterial	compliance,	with	highest	values	
in	periovulatory	phase.	The	fluctuation	in	carotid	arterial	elasticity	
correlated	with	the	changes	in	the	estrogen	to	progesterone	ratio	
[6].	Other	studies	evaluating	the	whole	body	arterial	compliance	
also	demonstrated	an	increase	in	arterial	compliance	in	the	peri-
ovulatory	period	 [20].	Only	one	 recent	 study,	performed	on	10	
healthy	nulliparous	women	presented	observations	in	accordance	
with	our	findings	[8].	Robb	et	al	observed	a	significant	decline	in	
AI	(by	almost	65%)	in	the	luteal	phase	when	compared	with	the	
periovulatory	period	using	similar	methodology.	These	conflict-
ing	results	could	have	been	due	to	different	methodologies	used,	
heterogeneity	of	populations	studies	and	low	numbers,	not	even	
approaching	normal	distribution,	of	the	populations	studied.	
Estradiol	 and	 progesterone	 receptors	were	 localized	 in	 the	
vascular	cells,	including	endothelium	and	vascular	smooth	mus-
cles	[1].	Experimental	studies,	both	in	human	and	animal	mod-
els,	demonstrated	that	estrogens	increased	vasodilator	responses,	
lowered	 coronary	 vascular	 resistance,	 diminished	 myocardial	
ischemia,	 decreased	 inflammation	 and	 atherosclerosis	 [21].	
Estrogens	 improve	 vascular	 reactivity,	 by	 promoting	 vasodila-
tion	 through	nitric	oxide	 (NO)	and	prostacyclin	 (PGI
2
)	produc-
tion,	and	by	inhibiting	the	production	of	vasoconstrictors	such	as	
endothelin	(ET-1)	and	angiotensin.	These	effects	were	exerted	on	
both	genomic	as	well	as	non-genomic	mechanism	via	membrane	
estrogen	receptors	[21].	Thus	we	might	have	expected	the	low-
est	vascular	resistance	and	highest	compliance	at	the	time	of	the	
periovulatory	 estradiol	 peak,	 i.e.	 in	 the	 late	 follicular	 phase	 of	
the	natural	cycle.	However,	other	endogenous	steroids,	predomi-
nantly	progesterone,	may	also	exert	direct	effects	on	the	vascular	
system	or	modulate	estrogen-induced	effects.	Thus	the	interplay	
between	estradiol	and	progesterone	may	be	more	important	than	
the	concentrations	of	estradiol	alone.	In	the	animal	models	pro-
gesterone	induces	NO-dependent	relaxation	of	aorta	and	periph-
eral	arteries,	increases	PGI
2
	production	and	has	anti-atherogenic	
effect	[22].	Nevertheless	progesterone	is	less	potent	vasodilator	
than	estradiol	and	in	some	models	it	was	also	shown	to	antago-
nize	the	vasoprotective	effects	of	estrogens	[23].	
Our	results	demonstrating	the	lowest	arterial	stiffness	in	the	
midluteal	phase,	characterized	by	the	highest	progesterone	levels	
and	 estradiol	 concentrations	 in	 the	upper	 ranges,	 suggest	 some	
additive	effects	of	both	hormones	on	vascular	compliance	at	the	
central	arteries.	However	lack	of	all	progesterone	measurements	
does	allow	for	the	detailed	analysis	of	estrogen	to	progesterone	
ratios	on	hemodynamic	parameters	and	vascular	stiffness.	
Data	 from	 randomized	 studies	 in	 postmenopausal	 women	
treated	with	 hormone	 replacement	 therapy,	 showing	 that	 exog-
enous	 estrogens	 increased	 arterial	 distensibility,	 and	 that	 this	
beneficial	effect	was	counteracted	by	progesterone	should	not	be	
directly	linked	to	our	observations	[2,	24].	Age-related	changes	
in	steroid	receptors,	their	distribution	and/or	affinity	may	contrib-
ute	to	the	differences	in	vascular	reactivity.	Moreover	age-related	
vascular	remodeling	and	changes	in	the	structure	of	blood	vessels	
may	result	in	different	responses	to	endogenous	as	well	as	exog-
enous	hormones	[1].
Conclusion
In	conclusion	the	present	study	demonstrates	significant	dif-
ferences	in	mechanical	properties	of	large	arteries	throughout	the	
natural	menstrual	cycle	in	young	and	healthy	females,	reflected	
by	changes	in	the	central	pulse	waveform.	Conversely	there	were	
no	changes	in	the	peripheral	blood	pressure	nor	in	peripheral	ar-
terial	stiffness	detected.	Significant	differences	in	hemodynamic	
parameters	during	 the	menstrual	 cycle,	 though	 small,	might	be	
taken	 into	account	when	performing	cardiovascular	assessment	
in	reproductive	age	women.	Further	studies,	on	larger	population	
with	 complete	 hormonal	 evaluation	 are	 needed	 to	 confirm	 our	
findings.
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